NO822086L - Fremgangsmaate ved fjerning av asparginsyre og glutaminsyre fra proteinhydrolysater og blandinger av aminosyrer - Google Patents
Fremgangsmaate ved fjerning av asparginsyre og glutaminsyre fra proteinhydrolysater og blandinger av aminosyrerInfo
- Publication number
- NO822086L NO822086L NO822086A NO822086A NO822086L NO 822086 L NO822086 L NO 822086L NO 822086 A NO822086 A NO 822086A NO 822086 A NO822086 A NO 822086A NO 822086 L NO822086 L NO 822086L
- Authority
- NO
- Norway
- Prior art keywords
- amino acids
- acid
- mixture
- solution
- glutamic acid
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims description 192
- 235000001014 amino acid Nutrition 0.000 title claims description 191
- 239000000203 mixture Substances 0.000 title claims description 169
- 235000013922 glutamic acid Nutrition 0.000 title claims description 55
- 239000004220 glutamic acid Substances 0.000 title claims description 55
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 title claims description 54
- 238000000034 method Methods 0.000 title claims description 32
- 108090000623 proteins and genes Proteins 0.000 title claims description 20
- 235000018102 proteins Nutrition 0.000 title claims description 18
- 102000004169 proteins and genes Human genes 0.000 title claims description 18
- 239000002253 acid Substances 0.000 title claims description 14
- 239000000243 solution Substances 0.000 claims description 82
- 235000003704 aspartic acid Nutrition 0.000 claims description 56
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 55
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 54
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 54
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 41
- 239000011347 resin Substances 0.000 claims description 31
- 229920005989 resin Polymers 0.000 claims description 31
- 229910021529 ammonia Inorganic materials 0.000 claims description 27
- 238000010828 elution Methods 0.000 claims description 25
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims description 21
- 239000003531 protein hydrolysate Substances 0.000 claims description 17
- 239000000872 buffer Substances 0.000 claims description 12
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims description 10
- 239000005695 Ammonium acetate Substances 0.000 claims description 10
- 229940043376 ammonium acetate Drugs 0.000 claims description 10
- 235000019257 ammonium acetate Nutrition 0.000 claims description 10
- 235000019270 ammonium chloride Nutrition 0.000 claims description 10
- 238000006460 hydrolysis reaction Methods 0.000 claims description 9
- 241001465754 Metazoa Species 0.000 claims description 6
- 230000007062 hydrolysis Effects 0.000 claims description 6
- 230000008569 process Effects 0.000 claims description 6
- 235000013311 vegetables Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 230000036961 partial effect Effects 0.000 claims description 3
- 239000003456 ion exchange resin Substances 0.000 claims description 2
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 239000003957 anion exchange resin Substances 0.000 claims 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 description 181
- 238000011084 recovery Methods 0.000 description 33
- 238000009472 formulation Methods 0.000 description 31
- 239000004475 Arginine Substances 0.000 description 21
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 21
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 21
- 229960003121 arginine Drugs 0.000 description 21
- 238000007792 addition Methods 0.000 description 16
- 235000016709 nutrition Nutrition 0.000 description 16
- 239000000460 chlorine Substances 0.000 description 15
- 230000035764 nutrition Effects 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 108010009736 Protein Hydrolysates Proteins 0.000 description 12
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 11
- 150000001768 cations Chemical class 0.000 description 11
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- 230000000670 limiting effect Effects 0.000 description 10
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 9
- 239000007858 starting material Substances 0.000 description 9
- 238000011282 treatment Methods 0.000 description 9
- 239000003792 electrolyte Substances 0.000 description 8
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 7
- 229910052801 chlorine Inorganic materials 0.000 description 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 7
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 6
- 150000005693 branched-chain amino acids Chemical class 0.000 description 6
- 229930182817 methionine Natural products 0.000 description 6
- 239000004474 valine Substances 0.000 description 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 5
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- -1 NaOH and KOH Chemical class 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 239000003480 eluent Substances 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 150000007529 inorganic bases Chemical class 0.000 description 5
- 229960000310 isoleucine Drugs 0.000 description 5
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 5
- 150000007530 organic bases Chemical class 0.000 description 5
- 235000016236 parenteral nutrition Nutrition 0.000 description 5
- 238000000746 purification Methods 0.000 description 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
- 208000014644 Brain disease Diseases 0.000 description 4
- 208000032274 Encephalopathy Diseases 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 206010040047 Sepsis Diseases 0.000 description 4
- 150000001450 anions Chemical group 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 239000005018 casein Substances 0.000 description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
- 235000021240 caseins Nutrition 0.000 description 3
- 239000003729 cation exchange resin Substances 0.000 description 3
- 229940023913 cation exchange resins Drugs 0.000 description 3
- 229920001429 chelating resin Polymers 0.000 description 3
- 230000007073 chemical hydrolysis Effects 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 2
- 150000008575 L-amino acids Chemical class 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 description 2
- 125000000129 anionic group Chemical group 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- 239000012362 glacial acetic acid Substances 0.000 description 2
- 230000002440 hepatic effect Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229960003104 ornithine Drugs 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000004064 recycling Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101000782236 Bothrops leucurus Thrombin-like enzyme leucurobin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010007733 Catabolic state Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020575 Hyperammonaemia Diseases 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 108010091205 Libid Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000006364 Torula Species 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- VREFGVBLTWBCJP-UHFFFAOYSA-N alprazolam Chemical compound C12=CC(Cl)=CC=C2N2C(C)=NN=C2CN=C1C1=CC=CC=C1 VREFGVBLTWBCJP-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003160 anti-catabolic effect Effects 0.000 description 1
- 150000001510 aspartic acids Chemical class 0.000 description 1
- 238000010923 batch production Methods 0.000 description 1
- 230000006931 brain damage Effects 0.000 description 1
- 231100000874 brain damage Toxicity 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 230000009615 deamination Effects 0.000 description 1
- 238000006481 deamination reaction Methods 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 150000002307 glutamic acids Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000007386 hepatic encephalopathy Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 210000002977 intracellular fluid Anatomy 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000012153 long-term therapy Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 238000011903 nutritional therapy Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 239000002510 pyrogen Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 235000021476 total parenteral nutrition Nutrition 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT22514/81A IT1205604B (it) | 1981-06-23 | 1981-06-23 | Procedimento per la eliminazione totale o parziale di acido aspartico e acido glutammico da idrolisati proteici e micele di amminoacidi con conseguete ottenimento di miscele di aminoacidi ad alto valore nutrizionale |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO822086L true NO822086L (no) | 1982-12-27 |
Family
ID=11197286
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO822086A NO822086L (no) | 1981-06-23 | 1982-06-22 | Fremgangsmaate ved fjerning av asparginsyre og glutaminsyre fra proteinhydrolysater og blandinger av aminosyrer |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4675196A (de) |
| JP (1) | JPS5829716A (de) |
| KR (1) | KR840000474A (de) |
| AU (1) | AU537254B2 (de) |
| BE (1) | BE893571A (de) |
| BR (1) | BR8203651A (de) |
| CA (1) | CA1215356A (de) |
| CH (1) | CH666189A5 (de) |
| DE (1) | DE3223150A1 (de) |
| DK (1) | DK281682A (de) |
| ES (1) | ES513333A0 (de) |
| FI (1) | FI822065L (de) |
| FR (1) | FR2507866B1 (de) |
| GB (1) | GB2103221B (de) |
| IT (1) | IT1205604B (de) |
| LU (1) | LU84218A1 (de) |
| NL (1) | NL8202538A (de) |
| NO (1) | NO822086L (de) |
| PT (1) | PT75098B (de) |
| SE (1) | SE8203912L (de) |
| ZA (1) | ZA824135B (de) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58126767A (ja) * | 1982-01-22 | 1983-07-28 | Ajinomoto Co Inc | 肝臓病患者用栄養組成物 |
| DE3916903A1 (de) * | 1989-05-24 | 1991-02-28 | Leopold Pharma Gmbh | Waessrige zusammensetzung fuer die parenterale ernaehrung |
| US5266685A (en) * | 1992-05-05 | 1993-11-30 | Grain Processing Corporation | Non-bitter protein hydrolyzates |
| US5276018A (en) * | 1992-07-17 | 1994-01-04 | Brigham And Women's Hospital | Composition comprising amino acids and methods for decreasing muscle breakdown |
| IL113299A (en) * | 1995-04-07 | 1999-03-12 | Amylum Nv | Process for the preparation of monosodium glutamate |
| IL116848A (en) * | 1996-01-22 | 2000-06-01 | Amylum Nv | Process for producing glutamic acid |
| US6960451B2 (en) * | 2002-02-06 | 2005-11-01 | Green Earth Industries | Proteolytic fermenter |
| US20040038391A1 (en) * | 2002-02-06 | 2004-02-26 | Pyntikov Alexander V. | Amino acids factory |
| US20040203134A1 (en) * | 2002-02-06 | 2004-10-14 | Pyntikov Alexander V. | Complex technologies using enzymatic protein hydrolysate |
| CA2510320C (en) | 2002-12-20 | 2012-10-09 | St. James Associates Llc/Faber Research Series | Coated particles for sustained-release pharmaceutical administration |
| US8697420B2 (en) * | 2008-05-20 | 2014-04-15 | Sempio Foods Company | Method for producing corn gluten hydrolysate and corn gluten hydrolysate using the same |
| KR100859098B1 (ko) * | 2008-06-13 | 2008-09-17 | 매일식품 주식회사 | 단백가수분해물로부터 천연 아미노산 함유 코쿠미조미료의제조방법 |
| US9987233B2 (en) | 2013-03-21 | 2018-06-05 | Eupraxia Pharmaceuticals USA LLC | Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith |
| EP3206672B1 (de) | 2015-10-27 | 2018-03-14 | Eupraxia Pharmaceuticals Inc. | Retard-formulierungen von lokalanästhetika |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE480943A (de) * | 1947-03-04 | |||
| US3015655A (en) * | 1955-07-18 | 1962-01-02 | John B Stark | Separation of nitrogenous organic compounds |
| US3045026A (en) * | 1959-05-06 | 1962-07-17 | Ogilvie Flour Mills Company Lt | Separation of amino acids by ion exclusion |
| IL36482A0 (en) | 1970-04-04 | 1971-05-26 | Istituto Ricerche Biomediche | The manufacture of natural amino acid mixtures from protein material |
| US3686118A (en) * | 1971-01-11 | 1972-08-22 | Durrum Chem Corp | Chromatographic method |
| US3920838A (en) * | 1973-09-04 | 1975-11-18 | Flatt Jean Pierre | Amino acid therapy |
| US4006032A (en) * | 1976-01-30 | 1977-02-01 | The United States Of America As Represented By The Secretary Of Agriculture | Process for removing off-flavor from maple sirup |
| DE2636828A1 (de) | 1976-08-16 | 1978-02-23 | Fresenius Chem Pharm Ind | L-amonosaeurengemische fuer die behandlung von leberinsuffizienz sowie die herstellung derartiger gemische |
| US4229342A (en) * | 1977-05-18 | 1980-10-21 | Rhone-Poulenc Industries | Process for extracting proteins from milk using silica and anion exchange resins |
| DE2946563A1 (de) * | 1979-11-17 | 1981-05-21 | B. Braun Melsungen Ag, 3508 Melsungen | Aminosaeureloesung zur parenteralen infusion |
| FR2478434B1 (de) * | 1980-03-21 | 1984-06-08 | Rhone Poulenc Spec Chim | |
| US4522836A (en) * | 1983-05-19 | 1985-06-11 | Mitco Water Laboratories, Inc. | Upflow ion exchange treatment of natural edible juices containing high acidity and suspended solids |
| US4514427A (en) * | 1983-05-19 | 1985-04-30 | Mitco Water Laboratories Inc. | Removal of bitter naringin and limonin from citrus juices containing the same |
-
1981
- 1981-06-23 IT IT22514/81A patent/IT1205604B/it active
-
1982
- 1982-06-09 CH CH3575/82A patent/CH666189A5/it not_active IP Right Cessation
- 1982-06-10 FI FI822065A patent/FI822065L/fi not_active Application Discontinuation
- 1982-06-10 GB GB08216900A patent/GB2103221B/en not_active Expired
- 1982-06-11 AU AU84806/82A patent/AU537254B2/en not_active Ceased
- 1982-06-11 ZA ZA824135A patent/ZA824135B/xx unknown
- 1982-06-14 CA CA000405101A patent/CA1215356A/en not_active Expired
- 1982-06-18 FR FR828210720A patent/FR2507866B1/fr not_active Expired
- 1982-06-21 BE BE2/59745A patent/BE893571A/nl not_active IP Right Cessation
- 1982-06-22 LU LU84218A patent/LU84218A1/fr unknown
- 1982-06-22 PT PT75098A patent/PT75098B/pt unknown
- 1982-06-22 JP JP57108240A patent/JPS5829716A/ja active Granted
- 1982-06-22 DE DE19823223150 patent/DE3223150A1/de active Granted
- 1982-06-22 NO NO822086A patent/NO822086L/no unknown
- 1982-06-22 ES ES513333A patent/ES513333A0/es active Granted
- 1982-06-23 BR BR8203651A patent/BR8203651A/pt unknown
- 1982-06-23 SE SE8203912A patent/SE8203912L/xx not_active Application Discontinuation
- 1982-06-23 DK DK281682A patent/DK281682A/da not_active Application Discontinuation
- 1982-06-23 NL NL8202538A patent/NL8202538A/nl not_active Application Discontinuation
- 1982-06-23 KR KR1019820002809A patent/KR840000474A/ko unknown
-
1984
- 1984-02-28 US US06/584,520 patent/US4675196A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU537254B2 (en) | 1984-06-14 |
| SE8203912D0 (sv) | 1982-06-23 |
| ES8304151A1 (es) | 1983-03-01 |
| PT75098A (en) | 1982-07-01 |
| GB2103221A (en) | 1983-02-16 |
| PT75098B (en) | 1985-05-31 |
| GB2103221B (en) | 1984-06-13 |
| IT8122514A0 (it) | 1981-06-23 |
| US4675196A (en) | 1987-06-23 |
| KR840000474A (ko) | 1984-02-22 |
| FR2507866B1 (fr) | 1989-12-29 |
| JPS5829716A (ja) | 1983-02-22 |
| DK281682A (da) | 1982-12-24 |
| ZA824135B (en) | 1983-04-27 |
| NL8202538A (nl) | 1983-01-17 |
| FR2507866A1 (fr) | 1982-12-24 |
| DE3223150A1 (de) | 1982-12-30 |
| IT1205604B (it) | 1989-03-23 |
| SE8203912L (sv) | 1982-12-24 |
| CH666189A5 (it) | 1988-07-15 |
| BE893571A (nl) | 1982-10-18 |
| BR8203651A (pt) | 1983-06-21 |
| DE3223150C2 (de) | 1988-08-11 |
| FI822065A0 (fi) | 1982-06-10 |
| CA1215356A (en) | 1986-12-16 |
| AU8480682A (en) | 1983-01-06 |
| LU84218A1 (fr) | 1983-01-20 |
| ES513333A0 (es) | 1983-03-01 |
| JPH0160017B2 (de) | 1989-12-20 |
| FI822065L (fi) | 1982-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO822086L (no) | Fremgangsmaate ved fjerning av asparginsyre og glutaminsyre fra proteinhydrolysater og blandinger av aminosyrer | |
| US3698912A (en) | Process for making nutrient composition | |
| Sauberlich | Studies on the toxicity and antagonism of amino acids for weanling rats | |
| Izumi et al. | Production and utilization of amino acids | |
| US4427658A (en) | Total enzymatic hydrolysate from whey proteins and process of obtaining the same | |
| AU2001237809B2 (en) | Pharmaceutical composition for muscular anabolism | |
| CA2567582C (en) | Anti-hypertensive dietary supplement derived from salmo or oncorhynchus protein hydrolysates | |
| JPH07114634B2 (ja) | ホスホペプチド、及び栄養又は治療用品 | |
| JPH049509B2 (de) | ||
| US5607840A (en) | Protein hydrolysate derived from mucosa tissue | |
| US5631031A (en) | Water-insoluble amino acid salt | |
| JPH05192089A (ja) | アミノ酸動物飼料添加物、その製造法および該添加物を含有する動物飼料またはプレミックス | |
| AU2001237809A1 (en) | Pharmaceutical composition for muscular anabolism | |
| Yamaguchi et al. | Preparation of corn peptide from corn gluten meal and its administration effect on alcohol metabolism in stroke-prone spontaneously hypertensive rats | |
| Zagon et al. | D-amino acids in organisms and food | |
| US2457820A (en) | Amino acid solution and process for preparing the same | |
| WO1993017581A1 (en) | A method for removing phenylalanine from proteinaceous compositions, a product so obtained and use thereof | |
| JPH05236909A (ja) | グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤 | |
| Thompson et al. | N5-(1-carboxyethyl)-ornithine, a new amino acid from the intracellular pool of Streptococcus lactis | |
| JPH04190797A (ja) | ペプチド混合物の製造法及びペプチド混合物を含有する飲料 | |
| JPS61233A (ja) | 水溶性乳漿蛋白質水解物の製造方法 | |
| JPS6287058A (ja) | 新規ペプチド | |
| Arai et al. | Comparative nutritional value for amino acids, oligopeptides and soybean protein | |
| Jenkins et al. | Nutritional characteristics of alkali-treated zein | |
| WO2002088667A2 (en) | ENANTIOSELECTIVE OLIGOMERIZATION OF α-HYDROXY CARBOXYLIC ACIDS AND α-AMINO ACIDS |